Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02824731 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 1 to 2v10
  2. Primary completion date: Oct 2025 to Oct 2027
    • Study completion date: Oct 2027 to Oct 2029
    • Eligibility criteria expanded, about 2 words
    v9
  3. Enrollment target: 346 to 555
    • Secondary endpoints revised (4)
    v8
  4. Primary completion date: Jul 2025 to Oct 2025
    • Study completion date: Jul 2026 to Oct 2027
    v7
  5. 3 versions Re-verified since Sep 13, 2017, no change to tracked fieldsv4-v6
Show 2 earlier versionsHide 2 earlier versions
  1. Phase: Phase 2 to Not applicablev3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This protocol compares the toxicity of radiotherapy or radiochemotherapy applied with different radiation modalities - protons or photons. Patients with different kinds of brain tumours and foreseen high-dose radiotherapy can be included. The hypothesis of the trial is that the rate of chronic toxicity 1 year after the end of radiotherapy is 15% lower after proton compared to photon treatment.
Trial Details
NCT Number NCT02824731
Lead Sponsor Technische Universität Dresden
Collaborators: German Cancer Research Center, National Center for Radiation Research in Oncology Dresden/Heidelberg
Conditions
(from sponsor)		 Brain Tumors
Related terms Brain Neoplasms
Enrollment 555 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov